tradingkey.logo

Tempus AI Inc

TEM
查看详细走势图
45.530USD
-1.230-2.63%
收盘 03/26, 16:00美东报价延迟15分钟
7.50B总市值
亏损市盈率 TTM

Tempus AI Inc

45.530
-1.230-2.63%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-2.63%

5天

-6.59%

1月

-17.83%

6月

-41.99%

今年开始到现在

-22.90%

1年

-14.50%

查看详细走势图

TradingKey Tempus AI Inc股票评分

单位: USD 更新时间: 2026-03-25

操作建议

Tempus AI Inc当前公司基本面数据相对健康,最新ESG披露属于行业领先水平。增长潜力很大。当前估值合理,在生物技术与医疗研究行业排名79/391位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价79.46。中期看,股价处于下降通道。近一个月,市场表现非常差,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Tempus AI Inc评分

相关信息

行业排名
79 / 391
全市场排名
189 / 4547
所属行业
生物技术与医疗研究

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

Tempus AI Inc亮点

亮点风险
Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
业绩高增长
公司营业收入稳步增长,连续3年增长139.14%
估值低估
公司最新PE估值-33.26,处于3年历史低位
机构加仓
最新机构持股95.93M股,环比增加4.64%
约翰·胡斯曼持仓
明星投资者约翰·胡斯曼持仓,最新持仓市值42.00K

分析师目标

根据 19 位分析师
买入
评级
79.461
目标均价
+61.70%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Tempus AI Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Tempus AI Inc简介

Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
公司代码TEM
公司Tempus AI Inc
CEOLefkofsky (Eric P)
网址https://investors.tempus.com/
KeyAI